Accustem Sciences (ACUT) Free Cash Flow Growth (3y) (2025 - 2026)

Accustem Sciences (ACUT) Free Cash Flow Growth (3y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Growth (3y) (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-1.95%
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-20.15%
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	21.16%
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	45.09%
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	80.69%
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-23.92%
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	8.92%
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-4.45%
10	Accustem Sciences	2.57 Mn	2.56 Mn	-	21.93%

Download Data